Key Dates

Related Announcements

December 31, 2024 - Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed). See NOFO PAR-25-338.

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this notice is to inform the research community that the Funding Opportunity Goal(s) statement for the PAR-25-338 “Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)” has been modified to reflect the broad mission of the NIH as opposed to a specific mission of any particular participating institute, center, or office.

Currently Reads:

Part 1. Overview Information

Funding Opportunity Goal(s): The overall goals of this NOFO are to improve screening and early detection strategies and to develop accurate diagnostic techniques and methods for predicting the course of disease in cancer patients.

Modified to Read (in bold italics):

Part 1. Overview Information

Funding Opportunity Goal(s): NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability.

All other aspects of PAR-25-338 remains unchanged.

Inquiries

Please direct all inquiries to:

Miguel R. Ossandon, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5714
Email: [email protected]